Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
This randomized phase III trial studies armodafinil to see how well it works in reducing cancer-related fatigue in patients with high grade glioma. Armodafinil may help relieve fatigue in patients with high grade glioma.
Research Base: Alliance for Clinical Trials in Oncology
NCT ID: NCT01781468
NCI Protocol Number: A221101
For more information see ClinicalTrials.gov
Armodafinil 150 mg; Placebo; Armodafinil 250 mg
Supportive Care/Symptom Management/PROs